Study identifies link between normal breast changes, cancer
Changes in mammary glands to accommodate breastfeeding may utilize a molecular process believed to help pre-malignant breast cells survives in mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 15, 2018 Category: Consumer Health News Source Type: news

Domestic Violence, PTSD and Triggers
People catch colds because they were exposed to a virus or infection.   Some people get cancer because cells have begun endlessly dividing in their body. We get itchy because an irritant has affected our skin.   We get hungry because our body needs nourishment on a regular basis, or thirsty because we aren’t sufficiently hydrated. I could go on and on … usually the things that we experience in our daily lives are a cause and effect thing; this happens because that happened, and so on. PTSD is similar, but also so very different. It happens when someone has experienced a traumatic event and...
Source: Psych Central - October 15, 2018 Category: Psychiatry Authors: Deborah Gray Tags: Personal Stories PTSD Trauma Abusive Relationship Domestic Violence Spousal Abuse triggers Source Type: news

Annual Meeting of National Academy of Medicine
Oct. 15 - The National Academy of Medicine is holding its annual meeting in Washington, D.C. Today's public events include a scientific program called Cancers: Can We Beat the Odds? and a President's Forum on affordable medications. Agenda | Webcast (Source: News from the National Academies)
Source: News from the National Academies - October 15, 2018 Category: Science Source Type: news

UCLA neurosurgeon named to National Academy of Medicine
Dr. Linda Liau, an internationally renowned neurosurgeon-scientist and chair of the neurosurgery department at theDavid Geffen School of Medicine at UCLA, has been elected by her peers to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.Membership honors people who have demonstrated outstanding professional achievements, commitment to service and contributions to the advancement of the medical sciences, health care and public health.A scientist in UCLA ’sJonsson Comprehensive Cancer Center, Liau has devoted the past 25 years to developing and refining treatment strategi...
Source: UCLA Newsroom: Health Sciences - October 15, 2018 Category: Universities & Medical Training Source Type: news

Chiropractor crackdown: College gives ultimatum on misleading health claims
There is no acceptable scientific evidence that chiropractors can treat Alzheimer's disease, cancer, diabetes, infertility, infections, autism, ADHD or Down syndrome. And yet, some practitioners in this province claim they can. (Source: CBC | Health)
Source: CBC | Health - October 15, 2018 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
PRINCETON, N.J., Oct. 15, 2018 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where t... Biopharmaceuticals, Oncology Soligenix, hypericin, cutaneous T-cell lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 15, 2018 Category: Pharmaceuticals Source Type: news

Palette Life Sciences and Nestlé Skin Health Enter into Global Licensing Agreement for Deflux(R), Solesta(R) and Barrigel(TM)
Transaction creates a fully-integrated specialty pharmaceutical company focused on improving patient outcomes for urology & urogynecology disorders, colorectal conditions, radiotherapy and interventional oncology procedures STOCKHOLM, Oct. 15, 2018 -- (... Biopharmaceuticals, Licensing Palette Life Sciences, Nestlé Skin Health, Deflux, Solesta, Barrigel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 15, 2018 Category: Pharmaceuticals Source Type: news

Boston's SQZ signs cancer drug pact with Roche worth up to $1B
Pharmaceutical giant Roche is re-upping its partnership with Boston startup SQZ Biotech, signing a collaboration deal on its lead cancer program that could be worth upwards of $1 billion. SQZ — pronounced "squeeze" — has developed a small chip that it hopes can allow proteins to penetrate a cell membrane, allowing the cells to be engineered in ways that other companies have struggled to do, according to founder and CEO Armon Sharei. The private biotech first signed a partners hip deal with… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 15, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO
STOCKHOLM, Oct 15, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) announced today its plans to concentrate its activities on clinical development. As a result, the board has appointed Dr. Uli Hacksell as the company'... Biopharmaceuticals, Oncology, Personnel Medivir, remetinostat, birinapant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 15, 2018 Category: Pharmaceuticals Source Type: news

Joint pain and falls among women with breast cancer on aromatase inhibitors - Basal C, Vertosick E, Gillis TA, Li Q, Bao T, Vickers A, Mao JJ.
PURPOSE: Arthralgia is common among women with breast cancer on adjuvant aromatase inhibitor (AI) therapy. Pain is associated with falls in the general population; however, little is known about the relationship between arthralgia and falls among AI users.... (Source: SafetyLit)
Source: SafetyLit - October 15, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Delving Where Few Others Have Gone, Leukemia Researchers Open New Path
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could improve AML survival rates, which have not budged in recent years. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - October 15, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

How to live longer: Citrus fruits can protect against cancer - why you should eat more
HOW TO live longer: A healthy, balanced diet is key to looking after the body and maintaining good health. Everyone knows they should be eating more fruit and veg, but citrus fruits in particular have essential health benefits. (Source: Daily Express - Health)
Source: Daily Express - Health - October 15, 2018 Category: Consumer Health News Source Type: news

Trainee barber, 24, whose rashes and itching were dismissed as eczema is battling blood cancer
Kaiser Khan, now 24, , from Stratford-upon-Avon, Warwickshire, was eventually forced to drop out of Liverpool John Moores University when his itching became unbearable. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2018 Category: Consumer Health News Source Type: news

Prostate cancer symptoms: This sign in the hips could signal the deadly disease
PROSTATE cancer symptoms are not always apparent in the early stages because they usually don ’t show until the tumour has grown and put pressure on other parts of the body. But when signs do begin to show, one to be wary of is in the hips. (Source: Daily Express - Health)
Source: Daily Express - Health - October 15, 2018 Category: Consumer Health News Source Type: news

UAMS Hopes Myeloma Audit Cuts to the Bone
The audit of the Myeloma Institute should be able to determine if there’s any money unaccounted for in the cancer program. The accounting is expected to be final after January. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - October 15, 2018 Category: American Health Source Type: news

Bug Behind Stomach Cancer Also Linked to Colon Cancer
Title: Bug Behind Stomach Cancer Also Linked to Colon CancerCategory: Health NewsCreated: 10/12/2018 12:00:00 AMLast Editorial Review: 10/15/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 15, 2018 Category: Cancer & Oncology Source Type: news

Contrast ultrasound helps characterize breast lesions
Adding contrast-enhanced ultrasound to conventional ultrasound improves diagnostic...Read more on AuntMinnie.comRelated Reading: Drop ultrasound contrast agent warning, society says Contrast US tops CT, MRI for classifying kidney tumors Contrast ultrasound is effective for liver, kidney lesions Contrast ultrasound identifies early cervical cancer Can CEUS differentiate between IBD and colon cancer? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 15, 2018 Category: Radiology Source Type: news

Radiologists influence cost of incidental MRI follow-up
When radiologists find incidental pancreatic cysts on MRI scans, patients can...Read more on AuntMinnie.comRelated Reading: Contrast US more accurately types pancreatic lesions Incidental imaging findings boost healthcare costs USPSTF seeks comment on pancreatic cancer guidance PET/MRI head scans reveal important incidental findings Primary care doctors want help with incidental findings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 15, 2018 Category: Radiology Source Type: news

Medical News Today: Aspirin may reduce liver cancer risk
The latest study to investigate the relationship between regular aspirin use and liver cancer risk finds a significant positive interaction. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 15, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research
Roche today announced the global commercial launch of three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits – the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. (Source: Roche Investor Update)
Source: Roche Investor Update - October 15, 2018 Category: Pharmaceuticals Source Type: news

Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research
Roche today announced the global commercial launch of three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits – the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. (Source: Roche Media News)
Source: Roche Media News - October 15, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Kadcyla reduced the risk of disease recurring in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced the phase III KATHERINE study met its primary endpoint, showing Kadcyla ® (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival, iDFS) compared to Herceptin® (trastuzumab) as an adjuvant (after surgery) treatment in people with HER2-positive early breast cancer (eBC) who have residual di sease (pathological invasive residual disease in the breast and/or axillary nodes) present following neoadjuvant (before surgery) treatment. (Source: Roche Investor Update)
Source: Roche Investor Update - October 15, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Kadcyla reduced the risk of disease recurring in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced the phase III KATHERINE study met its primary endpoint, showing Kadcyla ® (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival, iDFS) compared to Herceptin® (trastuzumab) as an adjuvant (after surgery) treatment in people with HER2-positive early breast cancer (eBC) who have residual di sease (pathological invasive residual disease in the breast and/or axillary nodes) present following neoadjuvant (before surgery) treatment. (Source: Roche Media News)
Source: Roche Media News - October 15, 2018 Category: Pharmaceuticals Source Type: news

CARTI Sees Improvement In Finances
Adam Head, CARTI’s president and CEO said the Little Rock cancer treatment center’s financial improvement for the fiscal year that ended June 30 should be defined as a “transformation." (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - October 15, 2018 Category: American Health Source Type: news

Investing in your employees ’ mental health is good business
Likely not visually apparent, your bottom line is bleeding due to a silent epidemic. Unaddressed mental illnesses are costing companies, whether they can see it or not. Mental illness is the No. 1 public health problem in the United States, more common than cancer, heart disease and diabetes combined. One in four people will face a serious mental health problem during their lifetime: that means you, a member of your family, or a close friend, an employee or a colleague. Why should we, the business… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 15, 2018 Category: Biotechnology Authors: Dr. Paul E. Keck, Jr. Source Type: news

Investing in your employees ’ mental health is good business
Likely not visually apparent, your bottom line is bleeding due to a silent epidemic. Unaddressed mental illnesses are costing companies, whether they can see it or not. Mental illness is the No. 1 public health problem in the United States, more common than cancer, heart disease and diabetes combined. One in four people will face a serious mental health problem during their lifetime: that means you, a member of your family, or a close friend, an employee or a colleague. Why should we, the business… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 15, 2018 Category: American Health Authors: Dr. Paul E. Keck, Jr. Source Type: news

Cancer survivors at risk for heart failure during, after pregnancy
(American College of Cardiology) Young women previously treated for cancer with chemotherapy or radiation therapy with a prior history of cardiotoxicity are more likely to develop clinical congestive heart failure (CHF) during and after pregnancy, according to a study published today in the Journal of the American College of Cardiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Financial impacts of cancer found to intensify disease burden among German patients
(European Society for Medical Oncology) A study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the US healthcare system where it has been associated with higher morbidity and mortality. The results to be presented at the ESMO 2018 Congress in Munich show that income loss is the main source of perceived financial hardship, and that this is associated with adverse psychological effects in patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Researchers identify a new way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Protein can be used to monitor patients and identify drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Blood test biopsy for kids with brain tumors is simple, safe way to see if treatment is working
(University of California - San Francisco) A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans, according to research led by UCSF Benioff Children's Hospitals and Children's National Health System. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

USC analysis solves puzzle of poor cancer prognosis in young Americans
(University of Southern California) For decades, some researchers believed cancer survival rates were dismally low among adolescents and young adults in the United States. A reexamination of long-term data by researchers at the Keck School of Medicine of USC and the Los Angeles Cancer Surveillance Program shows that 15- to 39-year-olds had the best survival of any age group for many years, and maintained that lead until pediatric cancer survival caught up. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Media Advisory: The New York Stem Cell Foundation Conference
(New York Stem Cell Foundation) The New York Stem Cell Foundation (NYSCF)'s 13th annual translational stem cell research conference convenes global leaders in stem cell research to present their latest progress towards new treatments and cures for the most devastating diseases and injuries in the world. The two-day conference will feature discussions on transformative new technologies in the field, moving research from the lab to the clinic, and current challenges facing regenerative medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

3D mammography detected 34 percent more breast cancers in screening
(Lund University) After screening 15 000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over 30 percent more cancers compared to traditional mammography - with a majority of the detected tumors proving to be invasive cancers. The extensive screening study was conducted by Lund University and Sk å ne University Hospital in Sweden, and the results are now published in the reputable journal Lancet Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

'Universal' blood test for earlier diagnosis of cancer moves closer to market
(University of Bradford) UK researchers behind a potential 'universal' liquid biopsy blood test for cancer detection have licensed the technology to an industrial partner to take it to market. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Purdue aims to find better drug 'fits,' avoid medication tragedies like thalidomide
(Purdue University) Purdue University researchers, including chemistry professor and Nobel Prize winner Ei-ichi Negishi, have developed technology to create a new chemical process to synthesize drug-like molecules with ultra-high purity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Young innovators
(University of Delaware) This month's special issue of the journal Cellular and Molecular Bioengineering, recognizes its Young Innovators Award winners. Two of the small group of honorees are from UD and have new research featured in the publication. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

The easy way may not be the best
(New York University) The steps cells take in response to challenges are more complex than previously thought, finds new research. The study investigates a system relevant to cancer, viral infection, and diabetes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 15, 2018 Category: Biology Source Type: news

More clues revealed in link between normal breast changes and invasive breast cancer
(Georgetown University Medical Center) A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

What is the Odds Ratio for Testicular Cancer after Cryptorchidism?
Discussion Cryptorchidism is the failure of one or both testes to descend from the abdomen into the scrotum. Congenital undescended testis (UDT)is common in young infants (1-4% in term infants and 45% in preterm infants) in that the testes will be palpable but remain high, but most testes will descend by 3-6 months and by 9 months of age only 1% remain undescended. The scrotum often appears underdeveloped. Sometimes the testes cannot be identified and is intra-abdominal at birth. Intra-abdominal testes are less likely to migrate to the scrotum and therefore are more likely to remain undescended. Acquired undescended test...
Source: PediatricEducation.org - October 15, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

#MayoClinicRadio podcast: 10/13/18
Listen: Mayo Clinic Radio 10/13/18 On the Mayo Clinic Radio podcast, Dr. Karthik Ghosh, former director of the Breast Diagnostic Clinic at Mayo Clinic, discusses the latest in?breast cancer screening and treatments. Also on the podcast, Dr. Ralph Gay, a physiatrist at Mayo Clinic, explains what can be done about low back pain.?And?Terri Wheeldon, a [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 15, 2018 Category: Databases & Libraries Source Type: news

Preteens' HPV Shot Won't Encourage Early Sex, Study Says
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Quercetin, a plant pigment, helps neutralize damage from toxic pesticides
(Natural News) At this point, there is no longer any doubt that the pesticides used on a massive scale in conventional farming are harmful to humans, animals and the environment. Exposure to pesticides has been linked to Parkinson’s disease, cancer, reproductive issues, diabetes, autism, asthma and Alzheimer’s disease in humans. Millions of birds and fish... (Source: NaturalNews.com)
Source: NaturalNews.com - October 14, 2018 Category: Consumer Health News Source Type: news

Prostate cancer symptoms: Three signs you have an advanced form of the disease
PROSTATE cancer symptoms are hard to spot as they usually don ’t become apparent until the tumour has grown large enough to affect the urethra. When the cancer has advanced and spread to other parts of the body, other signs may begin to show. (Source: Daily Express - Health)
Source: Daily Express - Health - October 14, 2018 Category: Consumer Health News Source Type: news

Reproduction revolution: how our skin cells might be turned into sperm and eggs
Scientists may soon be able to create human sperm and eggs using ordinary cells – a boon for those with fertility problems that raises troubling ethical questionsForty years ago, couples suffering from infertility were given hope by the birth of Louise Brown, the first “test-tube baby”. But although millions of babies have now been born by IVF, the technique can offer no help to couples eager to have a child that is genetically theirs but who lack the eggs or sperm to make it: men whose testes produce no sperm, say, or women who have undergone surgery for ovar ian cancer. Some opt for donor eggs or sperm,...
Source: Guardian Unlimited Science - October 14, 2018 Category: Science Authors: Philip Ball Tags: Genetics Reproduction Fertility problems IVF Biology Science Health Society Source Type: news

NUS researchers elucidate roles TP63 and SOX2 in squamous cell cancer progression
(National University of Singapore) Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore have identified a SCC-specific protein complex activated by TP63 and SOX2 which triggers a gene cascade that promotes SCC growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 14, 2018 Category: Cancer & Oncology Source Type: news

The teen battling cancer and 'living every day as it comes'
Billy White, 16, has cancer for the third time, but he's not letting it get him down. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 14, 2018 Category: Consumer Health News Source Type: news

Would you trust a £200 scanner to check your breasts at home? Ground-breaking new gadgets developed
Over the past three years, boffins have been focusing on women’s health concerns, from fertility and contraceptives to breast cancer and pregnancy care. (Source: the Mail online | Health)
Source: the Mail online | Health - October 14, 2018 Category: Consumer Health News Source Type: news

SCIENTISTS: A compound found in this Chinese herbal medicine can be used to treat skin cancer
(Natural News) According to a study in the journal BMC Complementary and Alternative Medicine, compound Muniziqi granule (MNZQ), a treatment used in China for many hormone-related issues, contains a compound that can cause the death of skin cancer cells. The study looked at the effects of MNZQ, a multi-component herbal preparation composed of ingredients from... (Source: NaturalNews.com)
Source: NaturalNews.com - October 13, 2018 Category: Consumer Health News Source Type: news

Bowel cancer symptoms: This sign could mean you have an advanced form of the disease
BOWEL cancer symptoms usually include a persistent change in bowel habit, blood in the stools and abdominal pain. But sometimes when the cancer grows and becomes advanced, another, less obvious sign can appear. (Source: Daily Express - Health)
Source: Daily Express - Health - October 13, 2018 Category: Consumer Health News Source Type: news